Tailoring therapy to the individual patient
This promotional module has been initiated, funded and reviewed solely by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by Practice Nurse.
Links to prescribing information can be found at the foot of this page.
The goals of therapy for type 2 diabetes are to prevent or delay complications and maintain quality of life. This requires control of glycaemia, management of cardiovascular risk factors, regular follow-up and importantly a patient-centred approach.1 This is in line with the Nursing and Midwifery Council (NMC) Code, which says that nurses should ‘prioritise people, practise effectively, preserve safety and promote professionalism and trust’.2 In addition, National Institute for Health and Care Excellence (NICE) guidelines emphasise the importance of taking into account individual needs and preferences.3
On completion of this module, you will:
This module is one of a series of five. Others in the series are:
This resource is provided at an intermediate level. Read the article and answer the self-assessment questions, and reflect on what you have learned.
Complete the resource to obtain a certificate to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.
1. Davies MJ, D’Alessio DA, Fradkin F, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018;41:2669-2701
2. Nursing and Midwifery Council. The Code: Professional standards and behaviours for nurses and midwives, 2015. https://www.nmc-uk.org/standards/code [Accessed July 2022]
3. NICE NG28. Type 2 diabetes in adults: management, 2015 (updated 2022) https://www.nice.org.uk/guidance/ng28 [Accessed July 2022]
Job Code: PC-GB-105041
Date of preparation: July 2022
You can sign up here to receive and manage your electronic communications from Boehringer Ingelheim and its agents acting on its behalf, about BI's products, services and events.